• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN
March 14, 2025 07:00 AM EDT
Peer Review

Mer­ck di­ver­si­ty leader to re­tire this sum­mer; Geron seeks com­mer­cial chops for next CEO

Alex Hoffman

Copy Chief

Kathy Wong

Editor

→ Ce­leste War­ren said in a LinkedIn post that she is re­tir­ing from Mer­ck on Ju­ly 7. War­ren joined Mer­ck in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Arc­turus’ stock halved af­ter mixed re­sults of mR­NA cys­tic fi­bro­sis ther­a­py, Covid-19 vac­cine de­lay

Roche in talks with US on drug pric­ing, sets out pipeline and deal­mak­ing am­bi­tions

Mod­er­na’s CMV vac­cine fails Phase 3 study, end­ing long-shot pre­ven­tion ef­fort

Ex­clu­sive: As­traZeneca-part­nered Pine­tree nears $47M Se­ries B for pro­tein de­graders

Fre­quent fly­ers: Top drug­mak­ers’ pri­vate jets de­scend­ed on DC more than 120 times this year, da­ta show

sponsored

The ad­vent of dig­i­tal ther­a­peu­tics and what it means for health­care

Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times